|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021308,
umls-concept:C0205210,
umls-concept:C0205265,
umls-concept:C0229671,
umls-concept:C0439792,
umls-concept:C0439793,
umls-concept:C0441889,
umls-concept:C0521390,
umls-concept:C0681842,
umls-concept:C1555582,
umls-concept:C1880904,
umls-concept:C1883709
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-20
|
|
pubmed:abstractText |
Prompt and precise measurement of neuronal damage in acute cerebral infarction is important to determine the prognosis of functional outcome. A feasible biochemical marker such as the neuron-specific enolase (NSE) level has been used to detect various diseases involving the central nervous system.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-41
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12533086-Aged,
pubmed-meshheading:12533086-Aged, 80 and over,
pubmed-meshheading:12533086-Biological Markers,
pubmed-meshheading:12533086-Case-Control Studies,
pubmed-meshheading:12533086-Female,
pubmed-meshheading:12533086-Humans,
pubmed-meshheading:12533086-Infarction, Anterior Cerebral Artery,
pubmed-meshheading:12533086-Magnetic Resonance Imaging,
pubmed-meshheading:12533086-Male,
pubmed-meshheading:12533086-Middle Aged,
pubmed-meshheading:12533086-Phosphopyruvate Hydratase,
pubmed-meshheading:12533086-Predictive Value of Tests,
pubmed-meshheading:12533086-Reproducibility of Results,
pubmed-meshheading:12533086-Severity of Illness Index
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level.
|
|
pubmed:affiliation |
Department of Neurology, Yongdong Severance Hospital, Yonsei University College of Medicine, Kangnam-gu, Seoul, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
